Disparities in hepatitis C among people aged 12–59 with no history of injection drug use, United States, January 2013–March 2020
While the HCV infection burden was highest among people with an IDU history, we found a sizeable burden among people without such a history. These findings support policies and practices aimed at addressing disparities among people needing treatment.
Authors
- Ruth Jiles (ORCID: https://orcid.org/0000-0002-7132-4008)
- Laurie K. Barker (ORCID: https://orcid.org/0000-0002-0215-5669)
- Eyasu H. Teshale (ORCID: https://orcid.org/0000-0001-5244-8251)
- Greta Kilmer (ORCID: https://orcid.org/0000-0002-6419-6706)
- Jaimie Z. Shing (ORCID: https://orcid.org/0000-0001-7064-4424)
- Kathleen N. Ly (ORCID: https://orcid.org/0000-0003-4331-1389)
Institutions
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- National Center for Chronic Disease Prevention and Health Promotion (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- National Cancer Institute (US)
Publication Details
- Journal
- Liver International
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1111/liv.16108
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Centers for Disease Control and Prevention